Akari Therapeutics
akaritx.comLocations
London, UK
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
IPO
founded in
2015
Akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. The company develops life-transforming treatments for autoinflammatory diseases involving the complement (C5) and leukotriene (LTB4) pathways. Akari Therapeutics was founded in 2015 and is headquartered in London, England.
Something looks off?Open jobs at Akari Therapeutics